Recent news on Reneuron

ReNeuron announces collaboration to enhance its stem cell ...  -  May 18, 2007
Oxfordshire Bioscience Network (press release),Guildford, UK, 18 May 2007: ReNeuron Group plc (LSE: RENE.L) today announced that it has signed a Research Collaboration Agreement with Kings College London

ReNeuron agrees collaboration deal to develop  -  May 18, 2007
Hemscott,LONDON (Thomson Financial) - ReNeuron Group PLC said it has signed a research collaboration agreement with King's College London to further develop the

ReNeuron to present at key European healthcare investor conference  -  May 11, 2007
PharmaLive.com (press release),The presentation will be webcast and available for viewing via the conference website or via the Company's website at www.reneuron.com.

ReNeuron to present at London stem cell conference.  -  May 2, 2007
Oxfordshire Bioscience Network (press release),Guildford, UK, 1 May 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will be participating in the 2nd European Stem Cells and Regenerative

ReNeuron welcomes European Parliament support for Advanced ...  -  May 2, 2007
Oxfordshire Bioscience Network (press release),Guildford, UK, 25 April 2007: ReNeuron Group plc (LSE: RENE.L) welcomes today's vote by the European Parliament to create a regulatory framework and single

ReNeuron welcomes EU parliament decision on advanced therapies ...  -  Apr 25, 2007
Hemscott,LONDON (Thomson Financial) - ReNeuron Group PLC said it welcomes today's vote by the European Parliament to create a regulatory framework and single

StemCells Announces First Quarter 2007 Financial Results  -  May 7, 2007
PharmaLive.com (press release),...gain of $718000 from the sale of approximately 5.3 million shares of common stock of ReNeuron Group plc ("ReNeuron") held as marketable securities,

StemCells 1Q Loss Widens  -  May 7, 2007
Forbes,The increase in operation expenses was offset somewhat by proceeds of the sale of an investment in ReNeuron Group PLC.

Small Cap Voice  -  May 10, 2007
TransWorldNews (press release),BD (US) NINDS (National Institute of Neurological Diseases), NIH, University College London, Advanced Cell Therapy (US), ReNeuron, Intercytex,

UK biotech in Parkinson’s drugs talks  -  26 Apr 2007
Business Online,Several other Parkinson’s drugs are being developed, including a stem-cell based treatment from fellow UK biotech ReNeuron, but none are as advanced as

ReNeuron welcomes EU parliament decision on advanced therapies ...  -  Apr 25, 2007
Hemscott,LONDON (Thomson Financial) - ReNeuron Group PLC said it welcomes today's vote by the European Parliament to create a regulatory framework and single

ReNeuron Receives Notice of European Patent Grant Covering Key ...  -  Apr 17, 2007
PharmaLive.com (press release),GUILDFORD, England, 17 April 2007: ReNeuron Group plc (LSE: RENE.L) today announced that it has received a notification of grant from the European Patent

ReNeuron awarded EU stem cell patents  -  Apr 18, 2007
In-PharmaTechnologist.com,18/04/2007 - The European Union Patent Office (EPO) has granted UK stem cell experts ReNeuron patent protection for three key human neural stem cell lines.

Reneuron Receives Notice of European Patent Grant Covering  -  Apr 17, 2007
ag-IP-news Agency,GUILDFORD, UK - ReNeuron Group plc announced on Tuesday that it has received a notification of grant from the European Patent Office concerning a patent

ReNeuron Group says receives EU patent for its human neural stem ...  -  Apr 17, 2007
Hemscott,LONDON (Thomson Financial) - Stem cell therapy company ReNeuron Group PLC said it has been granted a patent from the European Patent Office, covering the

Best hope lies in privately funded stem cell research  -  Apr 21, 2007
Chicago Sun-Times,Just last month, Fox's foundation made a significant contribution to ReNeuron, a private stem cell research laboratory. The actual dollar amount of the

UK small caps extend losses at midday; Max  -  Apr 12, 2007
Hemscott,Stem cell therapy company ReNeuron Group ticked 2-3/4 higher to 32 after it revealed that Saad Investments Company has raised its stake in the company to

ReNeuron to Present at Stem Cell 2007 Conference in Germany  -  Mar 6, 2007
PharmaLive.com (press release),SURREY, England, March 6, 2007--ReNeuron Group plc (LSE: RENE.L) today announces that its Chief Executive Officer, Michael Hunt, will present an overview of

ReNeuron Gains Revenue-share on New Cell Line Patent  -  Feb 26, 2007
PharmaLive.com (press release),26, 2007-ReNeuron Group plc today announces that it has entered into a revenue-sharing agreement with the international Ludwig Institute of Cancer Research

Reneuron in revenue-sharing deal on new cell  -  Feb 26, 2007
Hemscott,LONDON (AFX) - ReNeuron Group plc said it has entered into a revenue-sharing agreement with the international Ludwig Institute of Cancer Research (LICR) and

StemCells Announces Fourth Quarter and Year End 2006 Financial Results  -  Feb 28, 2007
Business Wire (press release),The increase in net loss from 2005 to 2006 was primarily attributable to the receipt in 2005 of shares of common stock of ReNeuron Group plc (“ReNeuron�) as

StemCells' Q4 loss widens by 37%  -  Feb 28, 2007
San Jose Business Journal,The company said the increase in net loss from 2005 to 2006 was primarily attributable to the receipt in 2005 of shares of common stock of ReNeuron Group

Reneuron -Allotment of shares. 16/02/07  -  Feb 19, 2007
Oxfordshire Bioscience Network (press release),Guildford, UK, 16 February 2007: ReNeuron Group plc announces the proposed issue to StemCells, Inc. (SCI) of 62543 new ordinary shares of 1p each fully paid

ReNeuron Announces £5.5 Million Fundraising  -  Feb 6, 2007
PharmaLive.com (press release),6, 2007: ReNeuron Group plc today announces that it proposes to place 18333333 new ordinary shares of 1p each credited as fully paid at a price of 30p per

ReNeuron to raise 5.5 mln stg from placing of  -  Feb 6, 2007
Hemscott,LONDON (AFX) - ReNeuron Group PLC said it plans to raise 5.5 mln stg before expenses from the placing of about 18.3 mln new shares at 30 pence each,

ReNeuron eyes £5.5m fundraising  -  Feb 6, 2007
ShareCast,LONDON (SHARECAST) - Stem cell group ReNeuron plans to raise £5.5m from a placing at 30p a share to help progress its ReN001 stem cell therapy for stroke

UK smallcap opening - ReNeuron better on placing news  -  Feb 6, 2007
Hemscott,LONDON (AFX) - Fundraising news was well received by holders of ReNeuron Group, 1-1/4 pence better at 35-1/4. The company plans to raise 5.5 mln stg before

Biotech firms hail biggest venture capital fund  -  Jan 30, 2007
Guardian Unlimited,Michael Hunt, of ReNeuron, the stem cell company that was forced to list on Aim after exhausting all other funding options, said: "It's very tough over here

$360m Deal-making CEO of Oxford-based Prosidion to Address BioTrinity  -  Jan 29, 2007
Emediawire (press release),...with the confirmed participation of many exciting young companies such as PIraMed, ReNeuron, VASTox, Chroma Therapeutics, Surface Therapeutics and Glide

Schepens sets Feb. 21 forum on treating 'blinding diseases'  -  Jan 27, 2007
Palm Beach Daily News,In a phone interview from his office in Boston, Gilmore said Schepens signed an agreement last year to receive stem cells for eye research from ReNeuron,

ReNeuron 'confident' in stem cell therapy, despite delay  -  Jan 17, 2007
In-PharmaTechnologist.com,17/01/2007 - ReNeuron remains confident that its new stem cell therapy for stroke will be approved to start clinical trials, despite a request for further

ReNeuron to Commence Phase I Study of ReN001, Stem Cell Therapy  -  Jan 12, 2007
PharmaLive.com (press release),Michael Hunt, Chief Executive Officer of ReNeuron, said: "We appreciate the diligence with which the FDA are reviewing our IND application for ReN001,

ReNeuron says can deal with US stem-cell concerns  -  Jan 12, 2007
Therapeutics Daily (subscription) (press release),LONDON (Reuters) - Britain's ReNeuron Group Plc said on Friday it believed it could address issues raised by US regulators concerning its pioneering new

ReNeuron says 'confident' of stem cell approval after FDA puts ...  -  Jan 12, 2007
Hemscott,LONDON (AFX) - ReNeuron Group PLC said it is 'confident' that approval to start human clinical studies with ReN001, its stem cell therapy for stroke,

ReNeuron Press Release: Regulatory Update  -  Jan 9, 2007
PharmaLive.com (press release),9, 2007: ReNeuron Group plc (LSE: RENE) today provides an update regarding its recently filed Investigational New Drug (IND) application to commence a Phase

FDA puts ReNeuron's stem cell stroke study on hold  -  Jan 10, 2007
Pharma Times (subscription),UK-based stem cell company ReNeuron says that the US Food and Drug Administration has placed on hold the company's recently-filed Investigational New Drug

Regulatory Update - Reneuron  -  Jan 9, 2007
Oxfordshire Bioscience Network (press release),ReNeuron is a leading, UK-based adult stem cell therapy business. It is applying its novel stem cell platform technologies in the development of

A Stroke for Stem Cells  -  Jan 14, 2007
Scientific AmericanReNeuron can generate large numbers of stable cell lines by engineering cells with a modified version of the gene c-myc. This gene promotes cell division

Reneuron says FDA puts stem cell stroke treatment phase I study on ...  -  Jan 9, 2007
Hemscott,LONDON (AFX) - Reneuron Group PLC said the US Food and Drug Administration has placed on hold its phase I clinical study of stem cell therapy for stroke.

UK smallcap opening - ReNeuron lower as clinical study put on hold ...  -  Jan 9, 2007
Hemscott,LONDON (AFX) - Sellers were about in ReNeuron Group, 7 pence lower at 37-1/2, after the company provided an update on its recently filed Investigational New

Wednesday tips round up: Marks & Spencer, Northgate, Savills  -  Jan 9, 2007
ShareCast,ReNeuron, which is developing stem cell therapies for Parkinson's disease, diabetes and diseases of the retina, is without doubt a high-risk bet,

Pro-Life Groups Opposed to Use of Aborted Foetuses in New Stroke ...  -  Jan 4, 2007
The Universe,UK biotech company ReNeuron wants to repair the damaged brains of stroke patients using stem cells from aborted foetuses. The company is seeking permission

Broker Tips: Credit Suisse upgrades Lloyds TSB and HBOS  -  Jan 9, 2007
CityWire.co.uk,In the small companies sector it recommends Halladale Group, Reneuron Group and SR Pharma as buys. JP Morgan is neutral on The Restaurant Group,

Stem-cell hope put on hold by US regulator  -  Jan 10, 2007
Guardian Unlimited,ReNeuron, a British company developing stem-cell therapies, suffered a setback yesterday when the US regulator put the group's first clinical trial on hold.

UK small caps close ahead, off intraday high  -  Jan 9, 2007
Hemscott,On the downside, meanwhile, shares in ReNeuron Group were hit by news the US Food and Drug Administration has orally confirmed that it has placed the

UK small caps open higher with Frontera Resources boosted by ...  -  Jan 9, 2007
Hemscott,Among losers, sellers were about in ReNeuron Group, 5-1/2 lower at 39, after the company provided an update on its recently filed Investigational New Drug

London shares remain firmer midday, Intercontinental Hotels jumps ...  -  Dec 27, 2006
Forbes,And New Year share tips from Daily Telegraph business staff gave a boost to small caps ReNeuron, up 2 pence to 39-1/2, and Mwana Africa, up a penny to 39.

London shares remain firmer midday, Intercontinental Hotels jumps ...  -  27 Dec 2006
Forbes,And New Year share tips from Daily Telegraph business staff gave a boost to small caps ReNeuron, up 2 pence to 39-1/2, and Mwana Africa, up a penny to 39.

ReNeuron Announces Results of Exercise of Warrants  -  Dec 14, 2006
PharmaLive.com (press release),14, 2006: ReNeuron Group plc (LSE: RENE) today announces that the Company has raised approximately £1.9 million from the proceeds of the exercise of

ReNeuron Group raises 1.9 mln stg via warrants exercise to fund ...  -  Dec 14, 2006
Hemscott,LONDON (AFX) - ReNeuron Group PLC said it has raised about 1.9 mln stg through the exercise of warrants to commence human clinical studies with its lead

ReNeuron Files IND Application to Commence Human Clinical Studies ...  -  Dec 6, 2006
PharmaLive.com (press release),This filing is a key milestone in ReNeuron’s history and, the Company believes, the world’s first such application concerning a neural stem cell treatment

ReNeuron files IND application to commence human clinical studies ...  -  Dec 6, 2006
Oxfordshire Bioscience Network (press release),ReNeuron Group plc (LSE: RENE.L) today announces the filing of its first Investigational New Drug (IND) application with the US Food and Drug Administration

ReNeuron up 96% as directors buy  -  Dec 7, 2006
ShareCast,LONDON (SHARECAST) - Stem cell pioneer ReNeuron nearly doubled in value today as directors bought shares following yesterday's US drug filing.

ReNeuron seeks to begin stem cell stroke trials; H1 losses narrow ...  -  Dec 6, 2006
Hemscott,LONDON (AFX) - ReNeuron Group PLC unveiled narrower interim losses and confirmed it has asked for permission to begin clinical trials of its experimental

ReNeuron Group Plc announces Re Agreement  -  Nov 29, 2006
Genetic Engineering News (press release),The development work, to be conducted in CellSeed's laboratories in Tokyo, will establish protocols for efficiently developing ReNeuron's patented

ReNeuron applies for US stem cell trial  -  Dec 6, 2006
ShareCast,LONDON (SHARECAST) - AIM listed ReNeuron has filed its first Investigational New Drug application with the US Food and Drug Administration to start human

ReNeuron requests human stem cell trials  -  Dec 6, 2006
Pharmaceutical Business ReviewUK biotechnology company ReNeuron has applied to the FDA for authorization to begin trials that will use the stem cells of fetuses to treat stroke patients

ReNeuron asks permission to begin human trials of key stem cell ...  -  Dec 5, 2006
Hemscott,LONDON (AFX) - British stem cell researcher ReNeuron Group PLC will announce tomorrow that it has filed for permission to begin testing its experimental

UK small caps open higher, with ReNeuron up  -  Dec 6, 2006
Hemscott,LONDON (AFX) - UK small caps were higher in early trade, mirroring the firmer trend of the wider market, with ReNeuron strong in response to news that the

ReNeuron seeks to begin stem cell stroke trials; H1 losses narrow  -  Dec 5, 2006
Hemscott,LONDON (AFX) - ReNeuron Group PLC unveiled narrower interim losses and confirmed it has for the first time asked for permission to begin testing its

ReNeuron Inks Collaboration Agreement with CellSeed  -  Nov 30, 2006
Genetic Engineering News (press release),ReNeuron and CellSeed signed a collaboration agreement to develop liver-cell culture systems for drug safety screening in the pharmaceutical industry.

ReNeuron, CellSeed to collaborate on development of liver cell ...  -  Nov 30, 2006
Hemscott,LONDON (AFX) - ReNeuron Group plc and CellSeed Inc, a privately owned tissue engineering company based in Tokyo, Japan, said they are going to collaborate

Stroke symptoms reversed by stem cell therapy?  -  Dec 11, 2006
DrugResearcher.com,UK-based ReNeuron have filed their first Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for ReN001,

Top ten retail investor buys & sells for week ending 15 December 2006  -  Dec 15, 2006
Easier,Elsewhere on the market, shares in small-cap stem cell pioneer ReNeuron have soared on news of new drug trials - it filed an Investigational New Drug

UK Researchers Seek Human Trials for Fetal Cell Stroke Therapy ...  -  Dec 6, 2006
Lifesite,BBC reported yesterday on ReNeuron’s request to the US Food and Drug Administration to begin human trials on 12 stroke patients.

Cells from foetuses offer hope to stroke victims  -  Dec 6, 2006
Yorkshire Post Today,Biotech company ReNeuron is seeking permission for trials from the US Food and Drug Administration (FDA), which regulates American research.

Stem cells may repair brain tissue after stroke  -  Dec 5, 2006
Scotsman,The UK biotech company ReNeuron is seeking permission for trials from the US Food and Drug Administration. They will involve taking stem cells from the

Foetal cell hope for stroke victims  -  Dec 5, 2006
Guardian Unlimited,The UK biotech company ReNeuron is seeking permission for trials from the US Food and Drug Administration (FDA), which regulates American research.

UK small caps close stronger, outperforming  -  Dec 6, 2006
Hemscott,ReNeuron was a top FTSE small cap riser today, adding over 30 pct in value with a 4.88 pence advance to 19.75 after the company unveiled narrower interim

UK small caps strong midday, outperforming  -  Dec 6, 2006
Hemscott,ReNeuron was the top FTSE small cap riser at midday, adding almost 30 pct in value with a 4.38 pence advance to 19.25 after the company unveiled narrower

DEAD TOT 'CURE' FOR STROKES  -  Dec 5, 2006
Mirror.co.uk,The UK biotech company ReNeuron is seeking permission from American regulators for trials next year. They will involve taking stem cells from the developing

Biotech guru sees more British firms going to US  -  Dec 12, 2006
ReutersL: Quote, Profile , Research), ReNeuron Group Plc (RENE.L: Quote, Profile , Research) and Plethora Solutions Holding Plc (PLE.L: Quote, Profile , Research).

Unholy Grail Found?  -  Dec 6, 2006
MedIndia,UK based company ReNeuron has appealed for permission of trials on twelve stroke patients. This will involve killing or aborting a human fetus at a

UK small caps close firmer, near session highs mirroring broader ...  -  Dec 11, 2006
Hemscott,ReNeuron more than doubled in value last week after accompanying interim results with news that it was to commence initial clinical trials in the US on its

UK small caps hold firm, near highs midday mirroring broader ...  -  Dec 11, 2006
Hemscott,Among the losers, ReNeuron shares ran into some profit-taking after a strong rise last week, losing 5.50 pence at 29.00. ReNeuron more than doubled in value

Guru sees biotech firms going to US  -  Dec 12, 2006
Independent Online,...seven young companies backed by Merlin, including Ark Therapeutics Group Plc, Vectura Group Plc , ReNeuron Group Plc and Plethora Solutions Holding Plc.

Market Report: Magners makes Miller dedicate time to C&C  -  Dec 7, 2006
Independent,In the small caps, Reneuron surged again after news on Wednesday that the company is seeking human trials for its embryonic stem cell stroke treatment.

Market report: Yesterday's trading  -  Dec 8, 2006
This is Money,After directors bought stock at 19½p, ReNeuron added 19p more for a two-day leap of 23⅞p. The biotech company lit the touchpaper after revealing it

UK Financial Stocks, Royal Bank Gain; Vedanta, Tesco Decline  -  Dec 6, 2006
BloombergReneuron Group Plc (RENE LN), a UK company that's developing treatments using stem cells, said it asked US regulators to start testing an experimental

UK small caps close down slightly, off lows; Surfcontrol jumps on ...  -  Dec 7, 2006
Life Style Extra,ReNeuron Group, meanwhile, almost doubled its market value as five directors boosted sentiment surrounding the stock by all buying shareholdings in the

Market report: Yesterday's trading  -  Dec 6, 2006
This is Money,Surrey-based stem cell specialist Reneuron scorched 4⅞p higher to 19¾p after revealing it is seeking US Food & Drugs Administration approval to

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional